The Boston-area facility linked to 170 cases of fungal meningitis, which has killed 14 people, may have violated licensing requirements, a health official says.
The New England Compounding Center in Framingham, Mass., produced about 14,000 doses of the injectable steroid methylprednisolone acetate used to treat back and joint pain. The facility was shipping thousands of doses of the steroid alone to at least 23 states, but Dr. Madeleine Biondolillo — director of the Department of Public Health’s Bureau of Health Care Safety and Quality at the Massachusetts Department of Public Health — said her agency was not authorized to monitor volume of doses.